Pantoprazole

Chemical formula: C₁₆H₁₅F₂N₃O₄S  Molecular mass: 383.37 g/mol  PubChem compound: 4679

Therapeutic indications

Pantoprazole is indicated for:

Gastro-oesophageal reflux disease

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Symptomatic gastro-oesophageal reflux disease.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Zollinger-Ellison syndrome

Population group: only adults (18 years old or older)

Zollinger-Ellison-Syndrome and other pathological hypersecretory conditions.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Reflux oesophagitis

Population group: only adults (18 years old or older)

Long-term management in reflux oesophagitis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prevention of relapse in reflux oesophagitis

Population group: only adults (18 years old or older)

Relapse prevention and additionally Reflux esophagitis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prophylaxis of NSAID associated benign gastric and duodenal ulcers

Population group: only adults (18 years old or older)

Preventive procedure and additionally at least one of
Duodenal ulcer caused by non-steroidal anti-inflammatory drug
Drug induced gastric ulcer

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Peptic ulcer

Population group: only adults (18 years old or older)

Gastric and duodenal ulcer.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Eradication of Helicobacter pylori

Population group: only adults (18 years old or older)

Helicobacter pylori gastrointestinal tract infection

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: PANTOPRAZOLE Powder for solution for injection
Summary of Product Characteristics (SPC) 2019: PANTOPRAZOLE 40mg Gastro-resistant tablets
Summary of Product Characteristics (SPC) 2019: PANTOPRAZOLE 20mg Gastro-resistant tablets
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈